These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12891899)

  • 1. [The effect of physical aging on the structural behavior of amorphous poly(vinylpyrrolidone) polymers].
    Zelkó R; Süvegh K
    Acta Pharm Hung; 2003; 73(1):46-50. PubMed ID: 12891899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
    Zelkó R; Orbán A; Süvegh K
    J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the release characteristics of theophylline and the free volume of polyvinylpyrrolidone.
    Zelkó R; Süvegh K
    Eur J Pharm Sci; 2005 Mar; 24(4):351-4. PubMed ID: 15734301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of storage conditions on the physical aging of amorphous polyvinylpyrrolidone].
    Zelkó R; Süvegh K
    Acta Pharm Hung; 2002; 72(2):123-6. PubMed ID: 12498039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H; Taylor LS
    Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physical ageing of amorphous polymeric excipients I. physicochemical principles].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2005; 75(4):213-22. PubMed ID: 16711399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro- and macrostructural characterization of polyvinylpirrolidone rotary-spun fibers.
    Sebe I; Kállai-Szabó B; Kovács KN; Szabadi E; Zelkó R
    Drug Dev Ind Pharm; 2015; 41(11):1829-34. PubMed ID: 25690306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
    J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the enthalpy recovery and free volume of polyvinylpyrrolidone during anomalous glassy to rubbery transition.
    Zelkó R; Süvegh K
    Eur J Pharm Sci; 2004 Mar; 21(4):519-23. PubMed ID: 14998583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approach.
    Gashi Z; Censi R; Malaj L; Gobetto R; Mozzicafreddo M; Angeletti M; Masic A; Di Martino P
    J Pharm Sci; 2009 Nov; 98(11):4216-28. PubMed ID: 19645003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
    Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
    Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pphysical ageing of amorphous polymeric excipients II. Tracking possibilities].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2006; 76(1):55-63. PubMed ID: 17094676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer structure and antimicrobial activity of polyvinylpyrrolidone-based iodine nanofibers prepared with high-speed rotary spinning technique.
    Sebe I; Szabó B; Nagy ZK; Szabó D; Zsidai L; Kocsis B; Zelkó R
    Int J Pharm; 2013 Dec; 458(1):99-103. PubMed ID: 24140543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
    Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).
    Xiang TX; Anderson BD
    J Pharm Sci; 2004 Apr; 93(4):855-76. PubMed ID: 14999724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of storage on microstructural changes of Carbopol polymers tracked by the combination of positron annihilation lifetime spectroscopy and FT-IR spectroscopy.
    Szabó B; Süvegh K; Zelkó R
    Int J Pharm; 2011 Sep; 416(1):160-3. PubMed ID: 21726620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.